MRI识别儿童骨肉瘤骨内范围的准确性研究
该回顾性诊断研究纳入55例因原发性骨肉瘤接受保肢手术的儿童患者,将切除标本长度叠加于术前MRI序列,比较MRI与组织病理学测量的骨内边缘。结果显示新辅助化疗后T1加权MRI与最终病理边缘相关性最强(r=0.846,p<0.001),平均差异最小(5.9 mm,SD=4.5 mm)。作者建议基于新辅助化疗后MRI规划手术时,应考虑到MRI显示肿瘤边缘与实际病理边缘之间可能存在最多1 cm的差异。
要点
- 新辅助化疗后T1加权MRI与最终组织病理学边缘相关性最强(r=0.846,p<0.001)。
- 新辅助化疗后T1加权MRI与病理边缘的平均差异最小,为5.9 mm(SD=4.5 mm)。
- 作者建议基于新辅助化疗后MRI规划切除时,应考虑到MRI与病理边缘差异可达1 cm。
核心结论
- 新辅助化疗后T1加权MRI与组织病理学边缘的相关性最强且平均差异最小。
- 基于新辅助化疗后MRI规划手术切除时,为安全起见应考虑到MRI显示肿瘤边缘与实际病理边缘之间可能存在的差异最多达1 cm。
研究设计与样本
- 回顾性研究,1999年8月至2015年7月期间由单一外科医生在单一机构因原发性骨肉瘤行保肢手术的211例可能合格患者。
- 131例(62%)患者病变累及股骨或胫骨,其中107例(51%)被分类为尤因肉瘤或骨肉瘤。
- 在线数据库中有记录可供审查的合格患者79例(37%);26例(12%)因临床或病理数据不足或不可用被排除,17例(8%)因MR成像不充分或不完整被排除,最终队列55例合格参与者(26%)。
- 将切除标本长度叠加于切除前MRI序列,比较MRI测量的边缘与组织病理学测量的边缘;采用算术平均差异和Pearson r相关系数评估定量准确性(边缘大小)。
主要发现
- 所有MRI类型均与最终组织病理学边缘呈正相关。
- 新辅助化疗后T1加权MRI与最终组织病理学边缘在所有MRI和时间点比较中呈最强正相关(r=0.846,p<0.001)。
- 新辅助化疗前T1加权MRI正常骨髓边缘与最终组织病理学边缘之间存在平均差异(t=8.363;均值18.883 mm;95%CI 14.327-23.441;p<0.001)。
- 新辅助化疗前T2加权MRI与最终组织病理学边缘之间存在平均差异(t=8.194;均值17.204 mm;95%CI 12.970-21.439;p<0.001)。
- 新辅助化疗后T1加权MRI与最终组织病理学边缘之间存在平均差异(t=10.808;均值22.178 mm;95%CI 18.042-26.313;p<0.001)。
临床怎么用
- 作者建议基于新辅助化疗后MRI规划手术切除时,为安全起见应考虑到MRI显示肿瘤边缘与实际病理边缘之间可能存在的差异最多达1 cm。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The quantitative accuracy of MRI in predicting the intraosseous extent of primary sarcoma of bone has not been definitively confirmed, although MRI is widely accepted as an accurate tool to plan limb salvage resections. Because inaccuracies in MRI determination of tumor extent could affect the ability of a tumor surgeon to achieve negative margins and avoid local recurrence, we thought it important to assess the accuracy of MR-determined tumor extent to the actual extent observed pathologically from resected specimens in pediatric patients treated for primary sarcomas of bone. QUESTIONS/PURPOSES: (1) Does the quantitative pathologic bony margin correlate with that measured on preoperative MRI? (2) Are T1- or T2-weighted MRIs most accurate in determining a margin? (3) Is there a difference in predicting tumor extent between MRI obtained before or after neoadjuvant chemotherapy and which is most accurate? METHODS: We retrospectively studied a population of 211 potentially eligible patients who were treated with limb salvage surgery between August 1999 and July 2015 by a single surgeon at a single institution for primary sarcoma of bone. Of 131 patients (62%) with disease involving the femur or tibia, 107 (51%) were classified with Ewing's sarcoma or osteosarcoma. Records were available for review in our online database for 79 eligible patients (37%). Twenty-six patients (12%) were excluded because of insufficient or unavailable clinical or pathology data and 17 patients (8%) were excluded as a result of inadequate or incomplete MR imaging, leaving 55 eligible participants (26%) in the final cohort. The length of the resected specimen was superimposed on preresection MRI sequences to compare the margin measured by MRI with the margin measured by histopathology. Arithmetic mean differences and Pearson r correlations were used to assess quantitative accuracy (size of the margin). RESULTS: All MR imaging types were positively associated with final histopathologic margin. T1-weighted MRI after neoadjuvant chemotherapy and final histopathologic margin had the strongest positive correlation of all MR imaging and time point comparisons (r = 0.846, p < 0.001). Mean differences existed between the normal marrow margin on T1-weighted MRI before neoadjuvant chemotherapy (t = 8.363; mean, 18.883 mm; 95% confidence interval [CI], 14.327-23.441; p < 0.001), T2-weighted MRI before neoadjuvant chemotherapy (t = 8.194; mean, 17.204 mm; 95% CI, 12.970-21.439; p < 0.001), T1-weighted after neoadjuvant chemotherapy (t = 10.808; mean, 22.178 mm; 95% CI, 18.042-26.313; p < 0.001), T2-weighted after neoadjuvant chemotherapy (t = 10.702; mean, 20.778 mm; 95% CI, 16.865-24.691; p < 0.001), and the final histopathologic margin. T1-weighted MRI after neoadjuvant chemotherapy compared with the final histopathologic margin had the smallest mean difference in MRI-measured versus histopathologic margin size (mean, 5.9 mm; SD = 4.5 mm). CONCLUSIONS: T1 MRI after neoadjuvant chemotherapy exhibited the strongest positive correlation and smallest mean difference compared with histopathologic margin. When planning surgical resections based on MRI obtained after neoadjuvant chemotherapy, for safety, one should account for a potential difference between the apparent margin of a tumor on an MRI and the actual pathologic margin of that tumor of up to 1 cm. LEVEL OF EVIDENCE: Level III, diagnostic study.
引用
- Thompson MJ, Shapton JC, Punt SE, et al. MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas. Clin Orthop Relat Res. 2018. PMID: 29529641. doi:10.1007/s11999.0000000000000068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。